GIP
LFCR icon

Granite Investment Partners’s Lifecore Biomedical LFCR Stock Holding History

Granite Investment Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,534
Closed -$343K – 316
2019
Q3 		$343K Sell
31,534
-51
-0.2% -$555 0.02% 294
2019
Q2 		$296K Sell
31,585
-27,634
-47% -$279K 0.02% 310
2019
Q1 		$727K Buy
59,219
+15,572
+36% +$190K 0.04% 271
2018
Q4 		$517K Hold
43,647
– – 0.04% 248
2018
Q3 		$629K Hold
43,647
– – 0.04% 220
2018
Q2 		$651K Hold
43,647
– – 0.04% 208
2018
Q1 		$570K Sell
43,647
-77,682
-64% -$1.02M 0.04% 208
2017
Q4 		$1.53M Hold
121,329
– – 0.1% 163
2017
Q3 		$1.57M Sell
121,329
-63,416
-34% -$836K 0.1% 162
2017
Q2 		$2.74M Sell
184,745
-72,910
-28% -$1.01M 0.19% 129
2017
Q1 		$3.09M Sell
257,655
-9,822
-4% -$124K 0.21% 118
2016
Q4 		$3.69M Sell
267,477
-22,915
-8% -$317K 0.27% 115
2016
Q3 		$3.89M Buy
290,392
+63,067
+28% +$764K 0.29% 117
2016
Q2 		$2.45M Buy
227,325
+9,954
+5% +$110K 0.19% 135
2016
Q1 		$2.28M Buy
217,371
+41,474
+24% +$456K 0.21% 137
2015
Q4 		$2.08M Sell
175,897
-20,115
-10% -$247K 0.19% 139
2015
Q3 		$2.29M Buy
196,012
+84,687
+76% +$1.12M 0.22% 132
2015
Q2 		$1.61M Sell
111,325
-28,554
-20% -$412K 0.15% 170
2015
Q1 		$1.95M Buy
139,879
+67,141
+92% +$928K 0.17% 167
2014
Q4 		$1M Buy
72,738
+42,848
+143% +$554K 0.11% 208
2014
Q3 		$366K Buy
+29,890
New +$373K 0.05% 246

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Granite Investment Partners's LFCR Position: Q4 2019 in Review

Granite Investment Partners sold out of Lifecore Biomedical (LFCR) in Q4 2019, closing a stake of 31,534 shares — an estimated $343K sold.

Granite Investment Partners first reported a position in LFCR in Q3 2014 and held it in 21 quarters. The position peaked at $3.89M in Q3 2016. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2019.

  • Granite Investment Partners reported no remaining Lifecore Biomedical position as of Q4 2019 after selling out during the quarter.
  • Granite Investment Partners sold 31,534 Lifecore Biomedical shares in Q4 2019, an estimated $343K.
  • Granite Investment Partners first reported a position in Lifecore Biomedical in Q3 2014 and held it in 21 quarters.
  • Granite Investment Partners's Lifecore Biomedical position peaked at $3.89M in Q3 2016.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2019.

Based on Granite Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.